Happy Thursday! This is Mind Your Business.

I've sat through enough AI pitches this year to know a good demo doesn't tell you much about what happens after somebody pays.

This week's Tampa Bay stories were more concrete. A drone maker landed a $40.5 million order, a cybersecurity startup raised $5.6 million, and a Tampa AI company is speeding up warranty decisions. Jabil wants to build AI hardware in India, and a biotech with Manatee County ties is working on a long-lasting HIV-prevention implant.

Worth watching: an order, a raise, a proposed venture and a grant are different kinds of progress.

🔔 WHAT JUST MOVED
Recent news from the last week shaping Tampa Bay right now.

Here's what's on the board:

🛸 6,000 Drones. $40.5 Million. And That's Just the Beginning
🛡️ Another $5.6M Flows Into Tampa Bay Cybersecurity
🖥️ A Multi-Gigawatt AI Hardware Play With a St. Pete Connection
🔧 A $30 Billion Problem. One Tampa Founder Thinks AI Has the Answer
🧬 One Implant. Years of Protection. A $9.6M Bet on Making It Possible
🍺 320,000 Businesses and a Data Opportunity Hiding in Plain Sight
🧪 1,000+ Clinical Trials. 35,000 Patients. Private Equity Comes Calling

Big checks, bigger opportunities, and a few moves worth watching.

Scroll down for the details…

🛸DEFENSE / ROBOTICS

Tampa-headquartered XTEND AI Robotics (NYSE: XTND) has a new test after its September stock-market debut: can it ship at scale?

On October 13, the company announced a $40.5 million order for 6,000 STRIKER systems after being selected as a top performer in the close-quarters segment of the U.S. military's $1 billion Drone Dominance Program.

STRIKER is designed to operate inside tight spaces and in places where satellite navigation doesn't work. XTEND also gets to bypass early selection steps for Gauntlet III, provided it first fulfills a 400-system production order. That next competition doesn't guarantee another contract.

⚡Why It Matters: A public listing gets attention. A 6,000-system order tests manufacturing, supplier capacity and delivery. The local question is how much of that work, and the hiring that could follow, lands in Tampa Bay.

🛡️CYBERSECURITY / VENTURE CAPITAL

Most businesses already own security tools. The harder part is figuring out which of the hundreds of warnings actually matter. Clearwater's Guardare just raised another $5.6 million to sell software that combines those alerts and ranks them by business risk.

Album led again, with Ten Eleven Ventures returning and Tampa Bay Ventures, DeepWork Capital and the Florida Opportunity Fund joining; an October 7 SEC filing shows $10.7 million in equity sold to date, not $10.7 million in this round alone.

CEO Lars Letonoff, whose résumé includes Sunbelt Software and KnowBe4, says the 25-person company will put the money into sales, marketing and product hires before pursuing a Series A.

⚡Why It Matters: Guardare is betting companies will pay to know which security problem to fix first, not to get another dashboard. That is a practical category to build, but it still takes real sales work to earn a spot in customers' budgets.

🖥️AI INFRASTRUCTURE / MANUFACTURING

Everybody wants more AI compute. Somebody still has to make the racks, servers and cooling equipment.

St. Petersburg-headquartered Jabil and India's Adani Enterprises signed a nonbinding agreement on October 13 outlining a proposed 50/50 joint venture to manufacture and assemble data-center hardware in India.

The companies are targeting a multi-gigawatt platform covering servers, networking, storage, power distribution and liquid cooling, with potential customers in India and abroad.

They announced plans to explore an alliance in June, so the new part is the proposed ownership structure. This is not a finalized joint venture: binding agreements and approvals are still required.

⚡Why It Matters: AI infrastructure isn't just about chips and models. It's power, cooling, manufacturing and supply chains. Jabil could have a bigger role in that buildout, but the next milestone is a signed deal, not a factory announcement.

🤖FEATURED EVENT / AI

AI is moving too fast for another event that spends the night explaining what it is.

On November 19, we're teaming up with Disrupt The Bay to bring together voices from Microsoft, Google, SOFWERX, RebelEdge Advisory and Byte Strategy AI to talk about the tools, workflows and real use cases worth paying attention to now.

Expect practical conversations, speed networking, food and drinks, and a room full of founders, operators, investors and technologists. Net proceeds will support pediatric cancer research through Save The Kids.

📅 November 19 | 5–8 PM
📍 SOFWERX, Tampa

→ Get your Techapalooza ticket

🔧AI / VENTURE CAPITAL

Ashok Kartham knows the service-software business. He built 4CS, which PTC acquired, and Mize, which merged with Syncron; now his Tampa company Circuitry.ai has a new growth investment led by Florida Funders, alongside DeepWork Capital and Tampa Bay Ventures.

The platform combines manuals, equipment records, parts catalogs and warranty terms so manufacturers can approve, deny or escalate claims without making people hunt through five systems. Florida Funders says one customer processes about 10,000 claims a month with it, although that figure comes from the investor, not an independent customer report.

⚡Why It Matters: This is the kind of AI I want to see more of: a repetitive, expensive decision and a result a buyer can measure. It's also another Tampa deal where local venture firms are backing software for a very specific job.

🧬BIOTECH / RESEARCH FUNDING

Imagine HIV prevention that doesn't require remembering a daily pill or returning for regular injections. Continuity Biosciences, which has a Manatee County connection, announced on October 14 that the Gates Foundation committed up to $9.6 million toward an implant designed to release prevention medicine over multiple years.

The foundation lists the commitment as September 2026; this week's news is the company's public announcement. The support is intended to advance the research toward a U.S. investigational-drug application and first-in-human testing. It is not an approved product, and multi-year protection has not yet been demonstrated in people.

⚡Why It Matters: Grant money can move high-risk medical research forward without forcing an early equity round. The science is promising, but safety and performance in human trials will matter much more than the size of the check.

🍺SOFTWARE / M&A

Tampa's Financial Information Technologies, better known as Fintech, already sees a huge share of the invoices and payments moving through the beverage alcohol industry.

It acquired Ground Signal, a market-intelligence company that tracks menus, consumer behavior and which brands are gaining ground in bars and restaurants. Fintech serves roughly 320,000 businesses, while Ground Signal brings data that can help suppliers see what customers are ordering, not just what stores and bars bought.

Founder Melki Ko and the Ground Signal team are joining the company. The purchase price was not disclosed.

⚡Why It Matters: Fintech already has the transaction layer. Buying the market-intelligence layer gives it more to sell to the same customers. Not every AI strategy needs to start with a chatbot.

🧠TICKLE YOUR BRAIN

A demo can suggest I exist.

An order is stronger proof.

Investors ask how much of me you have, and whether customers keep coming back.

Without me, a promising startup can stay promising forever.

What am I?

(Answer at the bottom. No peeking.)

🧪HEALTH CARE / PRIVATE EQUITY

Clinical Research of West Florida has been running trials since 1995, and it now has a new majority owner. Canadian firm Fengate Private Equity announced its acquisition on October 13.

The company operates three sites in Tampa and Clearwater, including an early-stage Phase I unit, and has supported more than 1,000 trials for nearly 300 sponsors and research organizations.

Its patient database includes more than 35,000 people. Fengate plans to expand into other markets and work with independent research sites; financial terms were not disclosed.

⚡Why It Matters: In clinical trials, access to patients and the ability to run studies well are valuable assets. The question for Tampa Bay is whether this deal brings more trial capacity, research jobs and sponsor work here.

😂MEME STREET

⚡QUICK HITS

✈️ FlyUSA Opens a 50K-SF Jet Hub at TPA
The company opened a 50,000-square-foot hangar on October 12. It can hold about 20 jets, depending on aircraft size, and now serves as FlyUSA's primary maintenance base.

🤖 An Orlando VC Backs a Hospital Robot Tested in Clearwater
Phase Shift Ventures invested in Gainesville-based Rovex Technologies. Rovex builds a robot that moves hospital beds and equipment, and has piloted it at BayCare's Morton Plant Hospital. The investment amount wasn't disclosed.

🏥 BayCare Opens a $33M Proton Therapy Center
BayCare opened its new center at St. Joseph's Hospital on October 14. Its system includes an upright treatment chair, an option designed to make some cancer treatments easier for patients who cannot lie flat.

🎭 Tampa Theatre Turns 100 Today
The historic theater reopened October 10 after a $24.5 million restoration. Its original opening date was October 15, 1926.

🚫 St. Pete Clarifies Its Standalone Data-Center Rules
An October 9 planning memo says standalone data centers are already excluded under existing zoning rules. It's a clarification, not a new ordinance, and a useful follow-up to last week's TECO power-demand story.

🎯OPERATOR’S TAKE

There's a difference between something that's been announced and something that's been proven.

XTEND has a big order to fulfill. Guardare has a new round to turn into sales. Circuitry.ai can point to warranty decisions moving through real workflows. Fintech bought data it believes its customers will pay to use.

Jabil's venture is still on paper. Continuity's implant still needs human testing. Both matter, but they're on a different part of the journey.

I've learned to ask three things when I hear a pitch: Who benefits? What changes in their day? How will we know it worked? If those answers aren't clear, another polished demo probably won't help.

That's also the conversation we're trying to have at Techapalooza on November 19th.

All the best,
Jon Tavarez

WORTHY MENTIONS

Market Signals
⚖️ Stock Market Fear & Greed: About 30 (FEAR)
₿ Bitcoin Dominance: About 59.5%
🛢️ WTI crude: $95.09 (+$6.81, +7.7% w/w)
📊 CPI: 3.7% y/y (core 2.6%)
🏭 PPI: +1.3% m/m, biggest since Mar 2022
👷 Jobs: +29K, unemployment 4.2%

Founder Perks
🎁 Bookkeeping + taxes: Get one month free with Collective on any tier.
👀 Founder network: Meet vetted founders through Hampton in small monthly peer groups.
🤯 Focus tools: Explore Graymatter, a plant-based daily drink.

Masterminds
🤗 Want to connect with founders, investors and innovators while helping produce our biggest events? Apply to volunteer.

📅 Want your company in front of 3,000+ Tampa Bay founders, investors and business leaders? Explore sponsorship and advertising.

❤️Love this newsletter? Forward it to a founder, investor, operator, or local business owner who should be paying attention to Tampa Bay.

📰Have news to share? Hit reply and send it our way.

RIDDLE ANSWER

Answer: Traction.

Simple explanation:
Traction is real-world evidence that customers want and use what you’re building: orders, repeat use and renewals. A promising demo is a start. A customer coming back is a stronger signal.

ADVERTISE WITH US // JOIN THE FB GROUP

*Please note that some of the links in this newsletter are affiliate links. This means that we may earn a small commission if you make a purchase through these links. We only recommend products or services that we believe will add value to our readers. Your support through these links helps us keep providing valuable content to you. Thank you for your support.